Cargando…
A striking response of plasmablastic lymphoma of the oral cavity to bortezomib: a case report
BACKGROUND: Plasmablastic lymphoma (PBL) is a rare and aggressive subtype of non-Hodgkin diffuse large B-cell lymphoma originally with a predilection to the oral cavity of patients infected with HIV. However, PBL of extraoral sites possesses clinicopathological characteristics distinct from oral PBL...
Autores principales: | Hirosawa, Makoto, Morimoto, Hiroaki, Shibuya, Ryo, Shimajiri, Shohei, Tsukada, Junichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4634743/ https://www.ncbi.nlm.nih.gov/pubmed/26543559 http://dx.doi.org/10.1186/s40364-015-0053-0 |
Ejemplares similares
-
Plasmablastic lymphoma of the oral cavity with breast recurrence: a case report
por: Samoon, Zarka, et al.
Publicado: (2015) -
Bortezomib, Ifosfamide, Carboplatin, and Etoposide in a Patient with HIV-Negative Relapsed Plasmablastic Lymphoma
por: Akce, Mehmet, et al.
Publicado: (2016) -
Oral plasmablastic lymphoma: A case report
por: Zizzo, Maurizio, et al.
Publicado: (2020) -
Reduced-intensity haploidentical peripheral blood stem cell transplantation using low-dose thymoglobulin for aggressive adult T cell leukemia/lymphoma patients in non-complete remission
por: Hirosawa, Makoto, et al.
Publicado: (2020) -
Oral plasmablastic lymphoma as the first manifestation of AIDS
por: do Vale, Daniela Assis, et al.
Publicado: (2017)